Please login to the form below

Not currently logged in
Email:
Password:

biologic

This page shows the latest biologic news and features for those working in and with pharma, biotech and healthcare.

London cancer hub launched by Cancer Research UK

London cancer hub launched by Cancer Research UK

The first research programme is aimed at discovering and developing new biologic cancer drugs, with an emphasis on the tumour microenvironment (TME) – i.e. ... Programme two will use imaging techniques to see how biologic treatments, such as cell

Latest news

More from news
Approximately 20 fully matching, plus 580 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 67 partially matching documents found.

Latest appointments

More from appointments
Approximately 7 fully matching, plus 45 partially matching documents found.

Latest from PMHub

  • It’s all about patient outcomes… right?

    a novel biologic agent. ... Consequently, the roll-out of the novel biologic agent was conducted in a manner that was sensitive to the PCP/specialist interaction observed, ensured smooth communications and optimised patient outcomes.

  • Biotech: it's a people business

    Biologic therapies have become a central part of modern day medicine and a key part of biotech and pharma portfolios.

  • Webcast: Biosimilars: Friend or Foe to Healthcare?

    Webcast: Biosimilars: Friend or Foe to Healthcare? Understanding the opportunities for biosimilars and the threats to innovator biologics. ... Gain greater insight into what companies entering the market need to do to effectively launch their follow-on

  • Infographic: RA Perceptions

    Partnership. An infographic highlights the key findings from the study. Biologic agents with novel mechanisms of action (such as Roche’ s RoActemra) are expected to outperform the overall EU biologics market ... Biosimilars (the approved follow-on

  • Biosimilars: Getting the flock to market

    originator biologic agent, offering comparable efficacy and safety but with a lower acquisition cost. ... So biosimilars not only increase patient access to tried and trusted biologics, they may accelerate adoption of new agents.

More from PMHub
Approximately 7 fully matching, plus 41 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics